NCT03951792Completed
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Source: ClinicalTrials.gov · Last updated 18 Apr 2024
Brief summary (registry, in English)
Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 220 (actual)
- First submitted
- 14 May 2019
- Start date
- 28 May 2019
- Primary completion date
- 15 Mar 2024
- Lead sponsor
- Mayo Clinic
- Diseases
- Colorectal cancer
- NCT number
- NCT03951792
What you commit to
- Study type: Observational
- Participants enrolled: 220
- From 28 May 2019 to the primary completion date, 15 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving or have received pelvic cancer radiation therapy in the past 2 weeks.
- Currently receiving or have received chemotherapy in the past 2 weeks.
Other
- Female that are pregnant
Who the study is looking for
- 18 years of age or older
- Patients undergoing bowel resection by any standard surgical approach.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.